← FDA DRUG APPROVALS
FDA NDA · NDA217512
PANTOPRAZOLE SODIUM
pantoprazole sodium in 0.9% sodium chloride
Sponsor: BAXTER HLTHCARE CORP
APPLICATION
NDA217512
TYPE
NDA
ORIGINAL APPROVAL
2024-02-14
LATEST ACTION
2024-02-14
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE · ReferencePrescription
PANTOPRAZOLE SODIUM EQ 80MG BASE/100ML (EQ 0.8MG BASE/ML) · SOLUTION · INTRAVENOUS
PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE · ReferencePrescription
PANTOPRAZOLE SODIUM EQ 40MG BASE/100ML (EQ 0.4MG BASE/ML) · SOLUTION · INTRAVENOUS
PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE · ReferencePrescription
PANTOPRAZOLE SODIUM EQ 40MG BASE/50ML (EQ 0.8MG BASE/ML) · SOLUTION · INTRAVENOUS
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.